ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

CBMX Combimatrix Corp. (MM)

6.25
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Combimatrix Corp. (MM) NASDAQ:CBMX NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 6.25 0.05 6.75 0 01:00:00

CombiMatrix to Present at Upcoming Investment Conferences

22/09/2015 11:00am

GlobeNewswire Inc.


Combimatrix Corp. (MM) (NASDAQ:CBMX)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Combimatrix Corp. (MM) Charts.

CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal developmental disorders and pre-implantation genetic screening services, announces that President and Chief Executive Officer Mark McDonough will present a company overview at the upcoming investment conferences:

  • Ladenburg Thalmann 2015 Healthcare Conference on Tuesday, September 29, 2015, at 4:00 p.m. Eastern time (1:00 p.m. Pacific time). The conference is being held at the Sofitel New York hotel in New York City.
  • 2015 Aegis Capital Growth Conference on Friday, October 9, 2015, at 10:45 a.m. Pacific time (1:45 p.m. Eastern time). The conference is being held at the Encore at Wynn Las Vegas hotel in Las Vegas.

A live webcast of the presentation at the Ladenburg Thalmann Conference will be available on the company's website at http://investor.combimatrix.com/events.cfm and will be archived for 30 days.

About CombiMatrix Corporation

CombiMatrix Corporation provides valuable molecular diagnostic solutions and comprehensive clinical support to foster the highest quality in patient care. CombiMatrix specializes in prenatal diagnostics, miscarriage analysis for recurrent pregnancy loss, pediatric genetics and pre-implantation genetic screening, offering DNA-based testing for the detection of genetic abnormalities beyond what can be identified through traditional methodologies. CombiMatrix performs genetic testing utilizing a variety of advanced cytogenomic techniques, including chromosomal microarray, standardized and customized fluorescence in situ hybridization (FISH) and high-resolution karyotyping. CombiMatrix is dedicated to providing high-level clinical support for healthcare professionals in order to help them incorporate the results of complex genetic testing into patient-centered medical decision making. Additional information about CombiMatrix is available at www.combimatrix.com or by calling (800) 710-0624.

CONTACT: Company Contact:
         Mark McDonough			
         President & CEO, CombiMatrix Corporation 
         (949) 753-0624 				
					
         Investor Contact:				
         LHA
         Jody Cain
         (310) 691-7100
         jcain@lhai.com

         Russo Partners LLC
         David Schull or Lena Evans
         (212) 845-4271
         david.schull@russopartnersllc.com
         lena.evans@russopartnersllc.com

1 Year Combimatrix Corp. (MM) Chart

1 Year Combimatrix Corp. (MM) Chart

1 Month Combimatrix Corp. (MM) Chart

1 Month Combimatrix Corp. (MM) Chart

Your Recent History

Delayed Upgrade Clock